logo

Mersana Therapeutics Inc: Navigating a Turbulent Year, Up -70.06% from 52-Week Low

Mersana Therapeutics Inc had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $9.62 on 06/12/23, while the lowest price during the same period was $0.80 on 07/27/23.

52-week price history of MRSN Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Mersana Therapeutics Inc’s current trading price is -70.06% away from its 52-week high, while its distance from the 52-week low is 259.37%. The stock’s price range during this period has fluctuated between $0.80 and $9.62. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.22 million for the day, which was evidently higher than the average daily volume of 2.16 million over the last three months.

Financial Performance and Market Capitalization

Mersana Therapeutics Inc (MRSN) has experienced a quarterly decline of -7.99% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 349.34M and boasts a workforce of 123 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 3.54, with a change in price of +1.29. Similarly, Mersana Therapeutics Inc recorded 2,213,861 in trading volume during the last 100 days, posting a change of +81.13%.

MRSN Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRSN stands at 0.92. Similarly, the long-term debt-to-equity ratio is also 0.77.

MRSN Stock Stochastic Average

Mersana Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 2.30%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 4.19%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.51% and 5.54%, respectively.

MRSN Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 24.14%.However, over the last six months, we can see a weaker performance of 98.62%. Over the last 30 days, the price of MRSN has leaped by -32.55%. And in the last five days, it has fallen by -18.18%.

Most Popular